Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin37.5%+8.9pp28.6%+3.2pp25.4%+4.0pp21.4%+5.2pp16.2%-8.0pp
Operating margin-83.3%+263pp-346.2%+84.5pp-430.6%+11.9pp-442.6%+96.9pp-539.4%-231pp
Net margin-80.3%+261pp-341.5%-14.1pp-327.3%+11.4pp-338.7%+94.6pp-433.3%-231pp
Returns
Return on equity-273.6%-60.1pp-213.5%-6.6pp-206.9%-16.1pp-190.8%-12.6pp-178.3%-127pp
Return on invested capital-304.3%-307.3%-19.8pp-287.5%-50.0pp-237.4%-146pp
Efficiency
Asset turnover0.2×0.0×0.2×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Liquidity
Current ratio5.7×+0.5×5.1×-1.1×6.2×-0.7×6.9×+0.2×6.7×-0.8×
Leverage
Debt-to-equity25.1×+14.4×10.7×+9.1×1.5×+0.7×0.9×+0.3×0.6×+0.5×
Per Share
Book value per share$0.01-56.7%$0.02-85.2%$0.12-41.4%$0.20-33.6%$0.31-82.4%
Valuation
Market capitalization$496.96M+30.4%$564.57M+46.8%$384.47M+6.8%$360.1M+2.5%$351.47M-34.7%
Price / sales3.1×+0.6×3.5×+1.0×2.5×+0.2×2.3×0.0×2.3×-1.2×
Price / book210×+206×105.5×+94.9×10.7×+4.8×5.9×+2.0×3.8×+2.8×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Pacific Biosciences of California's profit margins?
Pacific Biosciences of California (PACB) runs a 37.5% gross margin and a -83.3% operating margin, with a -80.3% net margin.
Where do Pacific Biosciences of California's ratios come from?
Every ratio is computed from Pacific Biosciences of California's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.